Solid Biosciences Inc (SLDB)
8.49
+0.56
(+7.06%)
USD |
NASDAQ |
Jun 13, 16:00
8.49
0.00 (0.00%)
After-Hours: 20:00
Solid Biosciences Price to Book Value: 1.546 for June 13, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 13, 2024 | 1.546 |
| June 12, 2024 | 1.444 |
| June 11, 2024 | 1.368 |
| June 10, 2024 | 1.424 |
| June 07, 2024 | 1.468 |
| June 06, 2024 | 1.406 |
| June 05, 2024 | 1.415 |
| June 04, 2024 | 1.430 |
| June 03, 2024 | 1.503 |
| May 31, 2024 | 1.504 |
| May 30, 2024 | 1.392 |
| May 29, 2024 | 1.377 |
| May 28, 2024 | 1.379 |
| May 24, 2024 | 1.419 |
| May 23, 2024 | 1.422 |
| May 22, 2024 | 1.528 |
| May 21, 2024 | 1.550 |
| May 20, 2024 | 1.661 |
| May 17, 2024 | 1.630 |
| May 16, 2024 | 1.694 |
| May 15, 2024 | 1.765 |
| May 14, 2024 | 1.814 |
| May 13, 2024 | 1.776 |
| May 10, 2024 | 1.892 |
| May 09, 2024 | 1.858 |
| Date | Value |
|---|---|
| May 08, 2024 | 1.842 |
| May 07, 2024 | 1.872 |
| May 06, 2024 | 1.797 |
| May 03, 2024 | 1.815 |
| May 02, 2024 | 1.838 |
| May 01, 2024 | 1.714 |
| April 30, 2024 | 1.594 |
| April 29, 2024 | 1.579 |
| April 26, 2024 | 1.613 |
| April 25, 2024 | 1.534 |
| April 24, 2024 | 1.576 |
| April 23, 2024 | 1.637 |
| April 22, 2024 | 1.624 |
| April 19, 2024 | 1.563 |
| April 18, 2024 | 1.664 |
| April 17, 2024 | 1.795 |
| April 16, 2024 | 1.764 |
| April 15, 2024 | 1.797 |
| April 12, 2024 | 1.862 |
| April 11, 2024 | 1.914 |
| April 10, 2024 | 1.944 |
| April 09, 2024 | 2.076 |
| April 08, 2024 | 2.138 |
| April 05, 2024 | 2.183 |
| April 04, 2024 | 2.223 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.26
Minimum
May 11 2022
29.71
Maximum
Dec 30 2020
2.203
Average
1.391
Median
Sep 22 2021
Price to Book Value Benchmarks
| Sarepta Therapeutics Inc | 12.29 |
| Catalyst Pharmaceuticals Inc | 3.225 |
| Pfizer Inc | 1.698 |
| PTC Therapeutics Inc | -- |
| Capricor Therapeutics Inc | 9.128 |
Price to Book Value Related Metrics
| PS Ratio | 14.08 |
| Price | 8.49 |
| Earnings Yield | -46.41% |
| Market Cap | 325.84M |